Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus.
about
A review of denosumab for the treatment of osteoporosisThe alliance of mesenchymal stem cells, bone, and diabetesEvolutionary medicine and bone loss in chronic inflammatory diseases--A theory of inflammation-related osteopeniaType 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer.Efficacy of Osteoporosis Therapies in Diabetic Patients.Effects of Noise Exposure on Systemic and Tissue-Level Markers of Glucose Homeostasis and Insulin Resistance in Male MiceThe association between the baseline bone resorption marker CTX and incident dysglycemia after 4 yearsEnzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease.Osteoclasts: more than 'bone eaters'.Biology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond.Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease.An integrated epigenomic analysis for type 2 diabetes susceptibility loci in monozygotic twins.Haptoglobin 2-2 genotype is not associated with cardiovascular risk in subjects with elevated glycohemoglobin-results from the Bruneck StudySesquiterpene lactones inhibit advanced oxidation protein product-induced MCP-1 expression in podocytes via an IKK/NF-κB-dependent mechanism.A Single 60 mg Dose of Denosumab Might Improve Hepatic Insulin Sensitivity in Postmenopausal Nondiabetic Severe Osteoporotic Women.Skeletal muscle insulin resistance in salt-sensitive hypertension: role of angiotensin II activation of NFκB.Osteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial InvasionNuclear factor κB-inducing kinase activation as a mechanism of pancreatic β cell failure in obesity.Effects of the anti-inflammatory drug salsalate on bone turnover in type 2 diabetes mellitusInterleukin-1β-Targeted Vaccine Improves Glucose Control and β-Cell Function in a Diabetic KK-Ay Mouse Model.Quantitation of the Rank-Rankl Axis in Primary Biliary Cholangitis.Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway.Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: a case reportRoles of TNF-α, GSK-3β and RANKL in the occurrence and development of diabetic osteoporosis.Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice.Wnt Signaling Inhibits Osteoclast Differentiation by Activating Canonical and Noncanonical cAMP/PKA PathwaysMolecular and genetic inflammation networks in major human diseases.Activation of PPARγ by a Natural Flavonoid Modulator, Apigenin Ameliorates Obesity-Related Inflammation Via Regulation of Macrophage PolarizationThe complement anaphylatoxin C5a receptor contributes to obese adipose tissue inflammation and insulin resistance.Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender DifferencesSerum Osteoprotegerin Is a Potential Biomarker of Insulin Resistance in Chinese Postmenopausal Women with Prediabetes and Type 2 Diabetes.Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaquesDiabetes mellitus and inflammation.Evolving therapies for non-alcoholic steatohepatitis.A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes.Energy Excess, Glucose Utilization, and Skeletal Remodeling: New Insights.Diabetic Retinopathy: Vascular and Inflammatory Disease.Deletion of a Distal RANKL Gene Enhancer Delays Progression of Atherosclerotic Plaque Calcification in Hypercholesterolemic Mice.NAFLD and diabetes mellitus.Bone-Derived Factors: A New Gateway to Regulate Glycemia.
P2860
Q27005894-CF4E8737-4FF8-485D-8A11-E548D181363BQ27012497-DCC7DB39-8AEA-463C-AD81-A104DC07F63EQ28088695-C3554FB8-ABAD-4458-B6B7-ADEC8A5A7ACDQ30234827-2285627E-CE71-4AA8-B9EF-39A5667EC631Q30248776-C7C4D289-15A6-4427-975B-F166F0FB8529Q30374509-0EBCE50D-963E-49E5-95D2-78A7D391B671Q33869676-4D77E49D-7BFA-47B8-B2AC-714E6CFF3510Q33886520-E6CCF85F-FB4C-4B8F-BD4F-357BEC0F2FB3Q33993757-0BD39BB0-D10A-4143-9B67-005D8B641D04Q34366449-1D8ED537-9AA5-4871-A3C7-54958CDCB300Q34444895-B2A83D56-327E-41FB-9401-E9AB38005424Q34833062-E3EC2164-F2EC-4AFA-A4B7-2F284C5FFCC3Q35021818-3468A329-BA0E-473E-A9E7-E9E1BED04369Q35022648-9DFC2B52-846F-4617-823B-8B82122672FCQ35248988-CBBB7144-130A-4EBB-8321-2860921EB7AFQ35576849-E8F4B4F6-0310-4179-92D5-608C853307F9Q35890262-EC7B463F-0028-4F4B-9EE4-A4745F95FB58Q35894344-EFA21552-3A49-40F8-B1CD-C314F859D6A3Q35908596-DD648D88-DE5D-4686-BA6C-3BB7E86ADAE2Q36010679-CAADB11A-9836-42B5-B907-0F0F0D827120Q36134061-9A2BCFEF-BA55-45A9-ABE9-4B49FC417D5BQ36135658-47FCA4DD-AD4D-4898-88A2-2F95C95FC8EDQ36203017-B7ECC39F-5228-4F08-BC8A-8E8B06B1A83DQ36374996-50DA6F38-41C3-4012-B662-B2DCD34FF89BQ36530849-FF422472-E8AA-4D80-AAD9-110B110543C7Q36593417-5A593869-6E1F-4D87-B68E-49A800A81A95Q37114392-23CC7028-3D5F-4291-AA92-503DE0A8BB3DQ37149978-F9F6ADF0-E087-4E2C-818F-3822F849A7A6Q37280702-38C6D03B-F34B-4051-9E46-95744793FAEAQ37511845-4D52B03B-FFF1-4485-B95E-F16DEDCB85EBQ37641079-0562685B-7DAF-4A22-B056-3B698A1D3C99Q37730682-1239A938-330D-466C-B060-034243196BC6Q38089671-6A3E6C37-96B4-44AE-A9F3-608DCB936BC6Q38207111-71CC5688-73B9-4AE3-8BF5-E5B9C49AF773Q38292347-A50F1B52-A19A-4C80-9E63-8E650CFF3D38Q38533278-D7BE1BF5-24F6-4C55-8546-48E8754E8C94Q38542115-E2264701-EF39-439E-9293-1D0C3D668013Q38832148-632CA6BF-7337-49AD-BCA9-858DA8F89DA6Q38978347-458CF044-7057-4DD3-B40F-4CFBA0EE28F0Q39004609-0EC338DF-BB09-4401-B87D-317928CF17AB
P2860
Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Blockade of receptor activator ...... elopment of diabetes mellitus.
@en
Blockade of receptor activator of nuclear factor-κB
@nl
type
label
Blockade of receptor activator ...... elopment of diabetes mellitus.
@en
Blockade of receptor activator of nuclear factor-κB
@nl
prefLabel
Blockade of receptor activator ...... elopment of diabetes mellitus.
@en
Blockade of receptor activator of nuclear factor-κB
@nl
P2093
P2860
P50
P356
P1433
P1476
Blockade of receptor activator ...... elopment of diabetes mellitus.
@en
P2093
Agnes Mayr
Aline Bozec
Andrea Giaccari
Dirk Mielenz
Friedrich Oberhollenzer
Georg Egger
Gian Pio Sorice
Herbert Tilg
Johann Willeit
Josef M Penninger
P2860
P2888
P304
P356
10.1038/NM.3084
P407
P50
P577
2013-02-10T00:00:00Z